We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

July 10, 2020

Measuring Digital Health Maturity: The Adoption of Digital Health Solutions by Payers in the US.

Reports
HealthXL Research Team
&

For long, healthcare payers have been digital laggards, seemingly reluctant to embrace the many opportunities and benefits digital (health) has to offer. Digital disruption, however, has begun encroaching on the industry! Slowly but surely we are seeing payers explore and embrace the true value and potential of digital and yet, it is difficult to ascertain to what extent leading insurers are actually engaging with digital to drive real change. With this in mind, this quarter, we assessed the digital health maturity of leading plans in the United States.

A recap of the self-assessed maturity of some of the top US health plans

Payer coverage is heavily dominated by six large health plans, however, plan innovation and new entrants are changing the landscape. Digital (health) offers payers many great opportunities to tackle some of the industry’s greatest challenges. The potential modalities of engagement are manifold and the solution types are even more diverse - ranging from screening and diagnostic solutions to administrative focused solutions. Digital health can help payers improve member satisfaction, increase efficiency, whilst lowering costs, create better member outcomes and collect higher quality member data. Payer investments in and partnerships with digital health companies have grown nearly exponentially since 2013 (see Humana’s investment in Livongo; Aetna’s partnership with Talkspace etc.)

Increases in investment acquisition and partnerships over the previous 5 years
Increases in investment acquisition and partnerships over the previous 5 years

While there is clear evidence that payers are engaging with digital, we delved deeper in this latest report, honing in on digital health strategy & vision, investments & partnerships, outcomes & impact, culture & leadership, as well as resources & support. We asked the top health plans directly and here is an excerpt of what they said about their digital maturity:

Strategy and vision

Our investigation suggests that payers are actively engaging in digital health, with nearly half of respondents having a solid digital health strategy in place. Our data also revealed that payers are active participants in the investment craze - 88.8% told us that they invest moderately to extensively in digital. As the world adjusts to living alongside Covid-19 and the remote ways of life, we expect this figure to continue to rise. So while initial investments in this space may have been tentative and high-risk, engagement with digital is now essential for business to remain afloat alongside competitors. 

Extent of US payer investments in digital health 

Outcomes and impact

We investigated how outcomes and impacts of digital health solutions are measured and if they align with organization and member objectives. Currently, digital health initiatives reach as little as 35,000 members and as many as 2 million. Despite the enormous potential, less than half of plans say they have been able to demonstrate positive member outcomes and impact through these initiatives. This result reveals that although the value of digital health is evident and intrinsic to business solutions, ROI is more difficult to establish (in the short term) and may take longer to quantify.

Range of members impacted by digital health initiatives
Range of members impacted by digital health initiatives

Culture and leadership

Digital is gaining traction and payers are focusing on creating an adaptive as well as flexible culture to facilitate digital transformation and innovation. We found that over half of payers adopt a digital-first mindset when it comes to finding new solutions. Although positive and encouraging, these organizational tendencies do not necessarily translate into meaningful initiatives, unless, they are truly championed at the top. 

Extent of digital first mindset among payer organizations
Extent of digital first mindset among payer organizations

Resources and Support

We discovered that payers are well resourced to manage their transition to digital. 75% have dedicated budgets and funding in place to support their digital health strategy. This result is very reassuring as access to essential resources and support sets the scene for a successful digital health journey!

Extent of digital strategy and dedicated digital health funding among payer organizations
Extent of digital strategy and dedicated digital health funding among payer organizations


So, what next? 

Results of our assessment demonstrate a clear digital evolution in the US payer market. Health Plans are aware of the opportunities and have a clear digital health vision and focus. The majority of the plans we spoke with through the course of this report have been dabbling with digital health initiatives more actively than we previously knew. This surprised us - in a good way! However, experimentation with new business models, large scale investing and partnering across the spectrum outside of ‘member wellness’ or ‘employee wellness’ is still in its nascency. 

We have the data and we’ve laid out the facts! Now we want your opinions!  For payers, this report shows how you stack up in your digital journey against your competitors. If you work in the payer healthcare space, and would like to provide us with your feedback or participate in our post-report survey, get in touch with us! 

The full report is accessible to all HealthXL members on our Insights Platform. 

Not a member, but would like a copy of the report? You can get a free preview of the report here. If you would like to get access to the full report, contact our customer team here.



We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

DTx-Generated RWD: What is the Value for Pharma?

27th June @ 10:45AM EDT

Real-world data (RWD) can be highly valuable to pharma companies; with several use cases from drug discovery and development to drug market access, label extensions, and understanding how their drugs and competitors are used in real life. Join this meeting to discuss this topic further with others working in this space.

Featuring
Myles Furnace
Myles Furnace
Commercial VP, Closed Loop Medicine
Brian Mahony
Brian Mahony
Medical Device & Digital Medicine Researcher, BioInnovate
Featuring
Myles Furnace
Myles Furnace
Commercial VP, Closed Loop Medicine
Brian Mahony
Brian Mahony
Medical Device & Digital Medicine Researcher, BioInnovate
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Sustainable Business Models for DTx in the US

30th June @ 10:45AM EDT
Cracking the US market is no mean feat for digital health companies.
Featuring
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Ary Deleray
Ary Deleray
Personalized & Digital Health Strategy at Roche
Featuring
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Ary Deleray
Ary Deleray
Personalized & Digital Health Strategy at Roche
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: Reimbursement of Digital Health in Europe - the DiGA framework

7th July @ 10AM EDT/ 5PM AWST

Regulatory clearance and the best commercialization model for a digital health product are among the key components for success in a rapidly growing sector. Join this Masterclass led by Flying Health to dive deeper into this topic.

Featuring
Laura Nelde
Laura Nelde
Startup Relationship Manager at Flying Health
Featuring
Laura Nelde
Laura Nelde
Startup Relationship Manager at Flying Health
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

What Label Claims can you make about your DTx?

14th July @ 10:45AM EDT

As the Digital Therapeutics (DTx) industry matures, regulation is becoming increasingly important. Join this meeting to share your experiences with others working in this space.

Featuring
Anish Shindore
Anish Shindore
Founder & Managing Partner, GSD Health
Brian Mahony
Brian Mahony
Medical Device & Digital Medicine Researcher, BioInnovate
Featuring
Anish Shindore
Anish Shindore
Founder & Managing Partner, GSD Health
Brian Mahony
Brian Mahony
Medical Device & Digital Medicine Researcher, BioInnovate

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

DTx-Generated RWD: What is the Value for Pharma?

27th June @ 10:45AM EDT

Real-world data (RWD) can be highly valuable to pharma companies; with several use cases from drug discovery and development to drug market access, label extensions, and understanding how their drugs and competitors are used in real life. Join this meeting to discuss this topic further with others working in this space.

Featuring
Myles Furnace
Myles Furnace
Commercial VP, Closed Loop Medicine
Brian Mahony
Brian Mahony
Medical Device & Digital Medicine Researcher, BioInnovate
Featuring
Myles Furnace
Myles Furnace
Commercial VP, Closed Loop Medicine
Brian Mahony
Brian Mahony
Medical Device & Digital Medicine Researcher, BioInnovate
Digital Health in Oncology
Digital Health in Oncology
Digital Health in Oncology
Digital Health in Oncology

Innovation Showcase: Digital Patient Support Programs (PSPs) in Oncology

28th June @ 10:45AM EDT

Are you a Digital Health company, Pharma executive, Medtech executive, or Venture Capitalist (VC), working in Patient Support Programs (PSPs) in oncology and seeking guidance to build successful partnerships? Then keep reading, this meeting is for you

Featuring
Fiona Clemente
Fiona Clemente
Digital Health Scouting Officer, WeHealth
Jim Ternyila
Jim Ternyila
Senior Digital Health Commercialization Strategy Leader, The Janssen Pharmaceutical Companies of Johnson & Johnson
Featuring
Fiona Clemente
Fiona Clemente
Digital Health Scouting Officer, WeHealth
Jim Ternyila
Jim Ternyila
Senior Digital Health Commercialization Strategy Leader, The Janssen Pharmaceutical Companies of Johnson & Johnson
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery

What’s in Remote Patient Monitoring Programs for Pharma?

29th June @ 10:45AM EDT

As the Covid-19 pandemic shifted how people interact with healthcare, the relationship between pharma and patients changed as many moved away from conventional clinical settings. Join this meeting to discuss this topic further and share your thoughts and experiences with your peers.

Featuring
Brian Flatley
Brian Flatley
VP Consulting Services at S3 Connected Health
Chris Wasden
Chris Wasden
Head of HappifyDTx, Happify Health
Featuring
Brian Flatley
Brian Flatley
VP Consulting Services at S3 Connected Health
Chris Wasden
Chris Wasden
Head of HappifyDTx, Happify Health
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Sustainable Business Models for DTx in the US

30th June @ 10:45AM EDT
Cracking the US market is no mean feat for digital health companies.
Featuring
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Ary Deleray
Ary Deleray
Personalized & Digital Health Strategy at Roche
Featuring
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Ary Deleray
Ary Deleray
Personalized & Digital Health Strategy at Roche

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.